Eighty-seven organizations representing patients with chronic and acute health conditions sent a letter to Congress urging them to improve the diversity of enrollment in clinical trials as part of this year’s Prescription Drug User Fee Act reauthorization.
Sarah Bigelow was named executive director of the Clinical Trials Office at the Tulane Cancer Center.
